Bicycle Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

Author's Avatar
May 04, 2023

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported financial results for the first quarter ended March 31, 2023 and provided recent corporate updates.